Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: News Summary Dashboard

Coca-Cola, Amazon And 3 Stocks To Watch Heading Into Tuesday - Benzinga neutral
KO YUMC MCD ST AMZN

Summary: Stock futures trading lower, expectations on earnings releases, and market reactions of various companies including Coca-Cola KO, Yum China YUMC, McDonald’s MCD, Sensata Technologies ST, and Amazon AMZN.

Full article
2024-04-30T10:01:37Z
US Chip Giant Nvidia Snaps Up 2 Israeli AI startups In Same Week - NoCamels somewhat bullish
NVDA

Summary: Nvidia has acquired Israeli AI software creator Deci AI, which specializes in generative AI models that can help companies reduce inference computing costs by up to 80 percent. This is Nvidia's second recent acquisition in Israel after purchasing Run:ai for $700 million.

Full article
2024-04-30T09:52:03Z
Union Pacific Testing First-of-its-Kind Hybrid Locomotive neutral
UNP

Summary: Union Pacific Railroad and ZTR are collaborating on the development and testing of hybrid battery-electric locomotives, aiming to improve fuel efficiency and reduce emissions in the freight rail industry.

Full article
2024-04-30T09:50:07Z
1 Wall Street Analyst Thinks Microsoft Stock Is Going to $500. Is It a Buy Around $400? very bullish
MSFT

Summary: Microsoft delivered impressive earnings growth in the fiscal 2024 third quarter led by strong adoption of its AI services, with revenue and EPS up 17% and 20% respectively. Analyst at Wells Fargo raised price target to $500 representing 25% upside potential. Stock is still considered fairly valued with room for further growth.

Full article
2024-04-30T09:49:49Z
Google Ads Performance Max Updates For Full-Funnel Optimization somewhat bullish
GOOGL

Summary: Google Ads has introduced updates to Performance Max campaigns including new Customer Value mode & Acquisition Goals, Winning Back Lapsed Customers, Detailed Demographics & Audience Insights, Budget Pacing Insights & Forecasting, Account-Level IP Address Exclusions, and Testing Optimization Strategies.

Full article
2024-04-30T09:49:45Z
J&J, Bristol Myers lose challenges to US drug price negotiation programme - Dunya News somewhat bearish
JNJ BMY

Summary: J&J and Bristol Myers lose challenges to the US drug price negotiation programme, allowing the government to set negotiated prices for their drugs under Medicare. This is part of President Biden's initiative to save $25 billion in drug costs annually by 2031.

Full article
2024-04-30T09:48:21Z
Dow Jones Futures Rise: Nvidia Leads New Buys; Tesla Runs Past Resistance On Elon Musk Move somewhat bullish
AAPL AMZN NVO LLY SMCI AMD NVDA AVGO ALAB APP KLAC CAVA ERJ HUBB WING TXRH GNRC TSLA

Summary: Dow Jones futures rose slightly Monday morning after a big week for the Nasdaq and leading stocks, with various companies reporting earnings and the latest Federal Reserve meeting and jobs report scheduled. The stock market rebounded strongly last week, fueled by big-cap earnings even amidst an alarming inflation report. AI chipmakers Nvidia, Broadcom, and Astera Labs are flashing buy signals, along with other stocks with earnings this week. Tesla stock jumped early Monday after CEO Elon Musk's visit to China where he reportedly won approval for Full Self-Driving.

Full article
2024-04-30T09:46:42Z
1 Wall Street Analyst Thinks Alphabet Stock Is Going to $200. Is It a Buy? | The Motley Fool very bullish
GOOG GOOGL

Summary: Alphabet (GOOG, GOOGL) reported strong growth in revenue and earnings, driven by AI investments and new features across its products. Several analysts increased their price targets for Alphabet stock after the earnings report, citing its momentum and shareholder-friendly capital returns.

Full article
2024-04-30T09:45:07Z
The Charles Schwab Co. (NYSE:SCHW) Receives $74.47 Consensus Target Price from Brokerages neutral
SCHW

Summary: Charles Schwab (NYSE:SCHW) has been assigned a consensus rating of "Hold" by fourteen research firms, with analysts giving two sell ratings, five hold ratings, and seven buy ratings. The average 1-year price objective is $74.47. Recent insider transactions include the CFO selling shares at an average price of $75.51. Several institutional investors and hedge funds have been buying and selling SCHW shares.

Full article
2024-04-30T09:45:03Z
MetLife, Inc. (NYSE:MET) Shares Acquired by Cwm LLC - Defense World somewhat bullish
MET

Summary: Cwm LLC increased its stake in MetLife, Inc. by 28.0% during the fourth quarter, while other hedge funds also made changes to their positions. Wall Street analysts have forecasted growth for MetLife and several research analysts have provided ratings and price targets on the stock. Insider transactions involving selling of MetLife shares have been reported. MetLife also announced an increase in its quarterly dividend.

Full article
2024-04-30T09:43:28Z
Is Palantir the Next Microsoft? - Yahoo Finance neutral
PLTR

Summary: Palantir Technologies' strong performance in 2023, with a 190% surge in share price, raises questions about its potential to become a major player in the tech industry, especially in the AI sector, akin to Microsoft. However, analyst Adam Spatacco believes Palantir's focus on software development may limit its growth compared to Microsoft's diversified business model.

Full article
2024-04-30T09:43:24Z
Gilead Sciences, Inc.'s (NASDAQ:GILD) Intrinsic Value Is Potentially 68% Above Its Share Price very bullish
GILD

Summary: Gilead Sciences is estimated to be undervalued by 40% based on a 2-stage Free Cash Flow to Equity model, with a fair value of US$132 compared to the current share price of US$78.68. The intrinsic value estimate is 44% higher than the analyst price target. The DCF model calculates a Total Equity Value of US$164 billion for Gilead Sciences.

Full article
2024-04-30T09:41:48Z
If You'd Invested $1000 in Wells Fargo 5 Years Ago, Here's How Much You'd Have Today somewhat bearish
WFC XLF

Summary: Wells Fargo stock has underperformed the overall stock market and financial sector peers over the past five years, with a 44.3% total return including dividends compared to the S&P 500's 89% and Financial Sector SPDR ETF's 63% return. Reasons for underperformance include effects of past scandals, operating under an asset cap imposed by the Federal Reserve, focus on commercial banking, and underperformance of value stocks like big banks compared to tech stocks.

Full article
2024-04-30T09:39:51Z
Bristol Myers Squibb: Tough Times Continue (NYSE:BMY) | Seeking Alpha somewhat bearish
BMY

Summary: Bristol Myers Squibb (NYSE:BMY) shares have come down 10%, after a huge first quarter loss related to recent dealmaking spree. The company faces challenges of debt and loss of exclusivity of top-selling drug. Despite a low share price, management needs to prove execution capability as a lot of work remains to be done.

Full article
2024-04-30T09:34:04Z
Oracle Fusion rollout costs 15 times council's estimates in SAP rip-'n-replace - The Register somewhat bearish
SAP ORCL

Summary: A local authority in England with a disastrous ERP system migration from SAP to Oracle has seen its expected cost rise from £2.6 million ($3.26 million) to nearly £40 million ($50 million). This increase in cost is due to various delays and difficulties experienced in the program.

Full article
2024-04-30T09:33:27Z
Microsoft to invest US$1.7 billion in cloud, AI in Indonesia, CEO says - CNA somewhat bullish
MSFT

Summary: Microsoft is set to invest US$1.7 billion in Indonesia to boost cloud and AI services, expanding its data centers and computing infrastructure in the region.

Full article
2024-04-30T09:33:05Z
Coca-Cola HBC Posts Organic Revenue Growth Of 12.6% In First Quarter | ESM Magazine very bullish
CCH.L

Summary: Coca-Cola HBC reported a 12.6% year-on-year organic revenue growth in the first quarter, driven by sparkling, energy, and coffee categories. The company achieved strong growth in emerging markets and launched new products in various segments.

Full article
2024-04-30T09:30:02Z
AVP US Banks Business Risk Management Reporting and Analysis | New York, NY, USA neutral
MS

Summary: Morgan Stanley is seeking an Assistant Vice President to join the First Line of Defense Business Risk team to support the newly created centralized risk reporting function, with responsibilities including planning and executing strategies for enhancing risk control environment and collaborating with stakeholders across multiple business functions.

Full article
2024-04-30T09:29:36Z
Federated Hermes Inc. Sells 14296 Shares of Emerson Electric Co. (NYSE:EMR) somewhat bullish
EMR FREE

Summary: Federated Hermes Inc. reduced its stake in Emerson Electric Co. by 52.6% in the 4th quarter, with other institutional investors also adjusting their positions. Wall Street analysts have given EMR a number of positive ratings and increased price targets in recent reports. Emerson Electric reported strong earnings results for the quarter, beating analysts' estimates and declaring a quarterly dividend.

Full article
2024-04-30T09:28:12Z
Billionaires Are Selling Nvidia and Buying This Artificial Intelligence (AI) Stock Instead neutral
AMZN NVDA

Summary: Several hedge fund billionaires began diversifying away from Nvidia in the fourth quarter, while purchasing shares of Amazon. Amazon has a strong presence in e-commerce, digital advertising, and cloud computing. Amazon is using artificial intelligence to strengthen its market presence. Straits Research says Amazon is a good stock to buy right now.

Full article
2024-04-30T09:27:53Z
FedEx donates 200 bicycles to help students reach schools in rural Africa neutral
FDX

Summary: FedEx Express, a subsidiary of FedEx Corp., has donated 200 bicycles and maintenance kits to youth in rural Africa in collaboration with Qhubeka Charity to improve access to education and empower young learners. The bicycles are aimed at helping students overcome transportation challenges hindering their studies.

Full article
2024-04-30T09:23:18Z
Forget Starbucks: Buy This Unstoppable Growth Stock Instead | The Motley Fool very bullish
CAVA

Summary: Cava Group (CAVA) is showing strong growth potential as a Mediterranean fast-casual chain, highlighted by its impressive revenue growth, expansion strategy, comparable sales surge, and strong restaurant-level operating margins.

Full article
2024-04-30T09:22:37Z
FedEx names winning startups for its 2024 Small Business Grant Contest in Asia Pacific neutral
FDX

Summary: FedEx Express announced the Winner of its 2024 Small Business Grant Contest (SBGC) in Asia Pacific, with companies in Indonesia, Malaysia, Philippines, and Singapore sharing a prize pool of $69,000. Lucence, Aerodyne, Fresh Factory, and SariSuki were recognized for their innovative business ideas and solutions.

Full article
2024-04-30T09:18:50Z
Wells Fargo Sticks to Its Hold Rating for Domino's Pizza (DPZ) | Markets Insider neutral
DPZ

Summary: Zachary Fadem from Wells Fargo maintained a Hold rating on Domino’s Pizza with a price target of $525.00; two reports including Citi also maintained a Hold rating on the stock with a price target of $530.00; Domino's Pizza reported quarterly revenue of $1.4 billion and a net profit of $157.29 million for the quarter ending December 31, showing growth from the previous year.

Full article
2024-04-30T09:17:47Z
Tether Invests $200M in Neural Implant Firm, Blackrock Neurotech - - Altcoin Buzz somewhat bullish
USDT

Summary: Tether has invested $200 million in neural implant company Blackrock Neurotech, making them a major stakeholder. The investment aims to expand Blackrock's market and improve their medical research in brain-computer-interface technology.

Full article
2024-04-30T09:14:21Z
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb - Morningstar somewhat bullish
BMY

Summary: Scenic Biotech enters into a research collaboration with Bristol Myers Squibb to accelerate the development of drug targets, gaining access to Scenic's Cell-Seq technology platform. Scenic will receive upfront payment and potential additional payments based on milestones achieved.

Full article
2024-04-30T09:12:40Z
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield ... somewhat bearish
NVDA T PFE

Summary: Prominent billionaire investors are decreasing their stakes in Nvidia due to skepticism of its long-term sustainability and increasing competition, while increasing their positions in high-yield dividend stocks AT&T and Pfizer.

Full article
2024-04-30T09:08:49Z